Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study

Secondary hyperparathyroidism in chronic kidney disease poses a major risk factor for vascular calcification and high bone turnover, leading to mineralization defects. The aim was to analyze the effect of active vitamin D and calcimimetic treatment on fibroblast growth factor 23 (FGF23), serum calci...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Katharina Dörr, Sebastian Hödlmoser, Michael Kammer, Roman Reindl-Schwaighofer, Matthias Lorenz, Bianca Reiskopf, Rahel Jagoditsch, Rodrig Marculescu, Rainer Oberbauer
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Subjects:	calcimimetic vitamin D calcification bone turn over hemodialysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.948177/full